237 related articles for article (PubMed ID: 17188473)
21. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
22. Enteric coated magnetic HPMC capsules evaluated in human gastrointestinal tract by AC biosusceptometry.
Corá LA; Romeiro FG; Paixão FC; Américo MF; Oliveira RB; Baffa O; Miranda JR
Pharm Res; 2006 Aug; 23(8):1809-16. PubMed ID: 16858651
[TBL] [Abstract][Full Text] [Related]
23. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
Kuentz M; Rothenhäusler B; Röthlisberger D
Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
[TBL] [Abstract][Full Text] [Related]
24. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
25. [A review on liquid-filled hard gelatin capsules].
Ma JH; Yang M; Zeng M; Chen XM; Lan J
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
[TBL] [Abstract][Full Text] [Related]
26. Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules.
Barham AS; Tewes F; Healy AM
Int J Pharm; 2015 Jan; 478(2):796-803. PubMed ID: 25526672
[TBL] [Abstract][Full Text] [Related]
27. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
Garbacz G; Cadé D; Benameur H; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
[TBL] [Abstract][Full Text] [Related]
28. Combined Application of MRI and the Salivary Tracer Technique to Determine the in Vivo Disintegration Time of Immediate Release Formulation Administered to Healthy, Fasted Subjects.
Sager M; Grimm M; Jedamzik P; Merdivan S; Kromrey ML; Hasan M; Koziolek M; Tzvetkov MV; Weitschies W
Mol Pharm; 2019 Apr; 16(4):1782-1786. PubMed ID: 30821987
[TBL] [Abstract][Full Text] [Related]
29. In vivo disintegration profiles of encapsulated and nonencapsulated sumatriptan: gamma scintigraphy in healthy volunteers.
Wilding IR; Clark D; Wray H; Alderman J; Muirhead N; Sikes CR
J Clin Pharmacol; 2005 Jan; 45(1):101-5. PubMed ID: 15601811
[TBL] [Abstract][Full Text] [Related]
30. The use of hypromellose in oral drug delivery.
Li CL; Martini LG; Ford JL; Roberts M
J Pharm Pharmacol; 2005 May; 57(5):533-46. PubMed ID: 15901342
[TBL] [Abstract][Full Text] [Related]
31. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.
Alhusban F; Perrie Y; Mohammed AR
Eur J Pharm Biopharm; 2011 Nov; 79(3):627-34. PubMed ID: 21693189
[TBL] [Abstract][Full Text] [Related]
32. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R
Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150
[TBL] [Abstract][Full Text] [Related]
33. Parameters affecting the drug release from in situ gelling nasal inserts.
Bertram U; Bodmeier R
Eur J Pharm Biopharm; 2006 Jul; 63(3):310-9. PubMed ID: 16513333
[TBL] [Abstract][Full Text] [Related]
34. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
35. Enteric coated HPMC capsules designed to achieve intestinal targeting.
Cole ET; Scott RA; Connor AL; Wilding IR; Petereit HU; Schminke C; Beckert T; Cadé D
Int J Pharm; 2002 Jan; 231(1):83-95. PubMed ID: 11719017
[TBL] [Abstract][Full Text] [Related]
36. Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules.
Hannula AM; Marvola M; Rajamaeki M; Ojantakanen S
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():221-7. PubMed ID: 1820883
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
Birchall JC; Jones BE; Morrissey A; Jones BE
Drug Dev Ind Pharm; 2008 Aug; 34(8):870-6. PubMed ID: 18686093
[TBL] [Abstract][Full Text] [Related]
38. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
Marvola T; Marvola J; Kanerva H; Ahonen A; Lindevall K; Marvola M
Int J Pharm; 2008 Feb; 349(1-2):24-9. PubMed ID: 17869037
[TBL] [Abstract][Full Text] [Related]
39. Effect of sodium bicarbonate and sodium starch glycolate on the in vivo disintegration of hard gelatin capsules--a radiological study in the dog.
Marvola M; Hannula AM; Ojantakanen S; Westermarck E; Rajamäki M
Acta Pharm Nord; 1989; 1(6):355-62. PubMed ID: 2560378
[TBL] [Abstract][Full Text] [Related]
40. Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules.
Huyghebaert N; Vermeire A; Remon JP
Eur J Pharm Sci; 2004 Apr; 21(5):617-23. PubMed ID: 15066662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
